Home/Pipeline/Decellularized Stented Heart Valve (DGH)

Decellularized Stented Heart Valve (DGH)

Surgical Aortic Valve Replacement

DevelopmentActive

Key Facts

Indication
Surgical Aortic Valve Replacement
Phase
Development
Status
Active
Company

About AutoTissue

AutoTissue is a private, commercial-stage biotech company pioneering glutaraldehyde-free, decellularized tissue implants for cardiovascular repair. Its core technology platform removes cellular material to minimize immunogenicity, with its lead commercial product, the Matrix Patch™ equine, used in pediatric cardiac surgery and adult aortic valve repair. The company operates a hybrid business model, combining product sales with contract research and manufacturing services, and is actively developing next-generation products like a decellularized stented heart valve.

View full company profile

Therapeutic Areas